Drugs for Neglected Diseases Initiative

533 papers and 18.6k indexed citations i.

About

In recent decades, authors affiliated with Drugs for Neglected Diseases Initiative have published 533 papers, which have received a total of 18.6k indexed citations. Scholars at this organization have produced 353 papers in Public Health, Environmental and Occupational Health, 267 papers in Epidemiology and 114 papers in Infectious Diseases on the topics of Research on Leishmaniasis Studies (279 papers), Trypanosoma species research and implications (234 papers) and Parasites and Host Interactions (96 papers). Their work is cited by papers focused on Public Health, Environmental and Occupational Health (12.2k citations), Epidemiology (9.8k citations) and Organic Chemistry (4.1k citations). Authors at Drugs for Neglected Diseases Initiative collaborate with scholars in Switzerland, United Kingdom and United States and have published in prestigious journals including Nature, Science and New England Journal of Medicine. Some of Drugs for Neglected Diseases Initiative's most productive authors include Eric Chatelain, Simon L. Croft, Jorge Alvar, Manica Balasegaram, Jean‐Robert Ioset, Piero Olliaro, Els Torreele, Thomas P. C. Dorlo, Isabela Ribeiro and Bernard Pécoul.

In The Last Decade

Fields of papers published by authors at Drugs for Neglected Diseases Initiative

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Drugs for Neglected Diseases Initiative at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Drugs for Neglected Diseases Initiative at the time of their publication.

Countries citing scholars working at Drugs for Neglected Diseases Initiative

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Drugs for Neglected Diseases Initiative. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Drugs for Neglected Diseases Initiative with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drugs for Neglected Diseases Initiative more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Rankless by CCL
2025